MAPS continues to be “optimistic about treatment coverage, but not naive for the troubles”. MDMA therapy will need special coverage underneath insurance policy, medicare, and medicaid. Far more information on protection will come as we in close proximity to FDA approval. When will other nations around the world authorize MDMA and on what terms?